Medical City Dallas Hospital Adopts Perimeter's Innovative OCT Imaging Technology for Surgery

Core Insights - Perimeter Medical Imaging AI, Inc. has announced the adoption of its S-Series OCT technology by Medical City Dallas Hospital for high-resolution visualization during surgeries, following the hospital's participation in a pivotal trial for the next-generation B-Series device [1][2] - The S-Series OCT technology, cleared by the FDA in 2021, provides real-time, cross-sectional imaging at the cellular level, making it suitable for identifying regions of interest in tissue microstructures [2][3] - The B-Series device, which integrates proprietary AI technology, is currently under evaluation by the FDA for use in breast-conserving surgeries [1][3] Company Overview - Perimeter Medical Imaging AI is based in Toronto and Dallas, focusing on transforming cancer surgery with advanced imaging tools that address significant medical needs [3] - The company’s S-Series OCT system is FDA-cleared and offers real-time visualization of excised tissues, while the investigational B-Series device has received a grant of up to US$7.4 million from the Cancer Prevention and Research Institute of Texas [3] Technology Details - The S-Series OCT is designed for evaluating excised human tissue microstructures, providing two-dimensional, cross-sectional, real-time depth visualization [4] - The technology is optimized for identifying features such as blood vessels, ducts, and glands, which are critical for visualizing surgical margins [2][4]